Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Journal of Breast Cancer
- Vol. 26 (2) , 136-151
Abstract
Yao L, et al. J Breast Cancer. 2023 Mar;26:e12. https://doi.org/10.4048/jbc.2023.26.e12Keywords
Funding Information
- National Natural Science Foundation of China (82203786)
- Natural Science Foundation of Liaoning Province (2022-YGJC-68)
- Chinese Young Breast Experts Research project (CYBER-2021-A02, CYBER-2022-001)
This publication has 33 references indexed in Scilit:
- The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast CancerAnnals of Surgical Oncology, 2012
- Pathological Complete Response and Accelerated Drug Approval in Early Breast CancerNew England Journal of Medicine, 2012
- Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast CancerAnnals of Surgical Oncology, 2011
- Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast CancerJapanese Journal of Clinical Oncology, 2011
- Pathologic complete response in breast cancer patients receiving anthracycline‐ and taxane‐based neoadjuvant chemotherapyCancer, 2010
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Accuracy of the Combination of Mammography and Sonography in Predicting Tumor Response in Breast Cancer Patients After Neoadjuvant ChemotherapyAnnals of Surgical Oncology, 2006
- Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinomaEuropean Journal of Cancer, 2006
- In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot studyAnnals of Oncology, 2005